Hypera (OTCMKTS:HYPMY) Shares Cross Above 50-Day Moving Average – What’s Next?

Hypera S.A. (OTCMKTS:HYPMY)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $3.34 and traded as high as $3.59. Hypera shares last traded at $3.59, with a volume of 308 shares.

Hypera Trading Up 1.4 %

The stock’s fifty day simple moving average is $3.35 and its two-hundred day simple moving average is $3.63. The firm has a market cap of $2.27 billion, a PE ratio of 8.98 and a beta of 0.99. The company has a quick ratio of 1.41, a current ratio of 1.81 and a debt-to-equity ratio of 0.68.

Hypera (OTCMKTS:HYPMY) last posted its quarterly earnings results on Thursday, March 20th. The company reported $0.02 earnings per share for the quarter. Hypera had a return on equity of 13.18% and a net margin of 20.04%. The company had revenue of $258.56 million for the quarter.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.